In a different model of respiratory infection, CXCL5 has been reported to affect B lymphocyte accumulation in the lungs of influenza virus-infected mice by regulating the expression of the CXCL13 chemokine and orchestrating the antiviral innate and adaptive immune responses27. Here, CXCL13 is linked to respiratory tract infectious disorder.